Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
Gut Microbes. 2023 Jan-Dec;15(1):2221821. doi: 10.1080/19490976.2023.2221821.
Despite significant achievements in hematopoietic stem cell transplantation (HSCT), graft-versus-host disease (GVHD), especially intestinal GVHD, remains a major obstacle to this procedure. GVHD has long been regarded as a pathogenic immune response, and the intestine has been simply considered as a target of immune attack. In effect, multiple factors contribute to intestinal damage after transplantation. Impaired intestinal homeostasis including altered intestinal microbiome and epithelial damage results in delayed wound healing, amplified immune response and sustained tissue destruction, and it may not fully recover following immunosuppression. In this review, we summarize factors leading to intestinal damage and discuss the relationship between intestinal damage and GVHD. We also describe the great potential of remodeling intestinal homeostasis in GVHD management.
尽管造血干细胞移植(HSCT)取得了重大进展,但移植物抗宿主病(GVHD),特别是肠道 GVHD,仍然是该手术的主要障碍。GVHD 长期以来一直被认为是一种致病免疫反应,而肠道只是被简单地认为是免疫攻击的靶标。实际上,多种因素导致移植后肠道损伤。肠道微生物组改变和上皮损伤导致的肠道内稳态受损会导致伤口愈合延迟、免疫反应放大和持续的组织破坏,并且在免疫抑制后可能无法完全恢复。在这篇综述中,我们总结了导致肠道损伤的因素,并讨论了肠道损伤与 GVHD 之间的关系。我们还描述了重塑 GVHD 管理中肠道内稳态的巨大潜力。